Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$9.2M |
 |
AmarinAMRN |
$1.2M |
 |
Gilead SciencesGILD |
-$81M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$4.8M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Colangelo Dominick | Jun 13, 2024 | Sell | 17,500 | $43.1 | $750,000 |
| Hopper Jonathan Mark | May 20, 2024 | Sell | 10,000 | $49.99 | $500,000 |
| Colangelo Dominick | May 16, 2024 | Sell | 17,500 | $47.85 | $840,000 |
| Colangelo Dominick | Apr 18, 2024 | Sell | 17,500 | $44.59 | $780,000 |
| ZERBE ROBERT L MD | Mar 27, 2024 | Sell | 3,278 | $51.57 | $170,000 |
| Colangelo Dominick | Mar 14, 2024 | Sell | 17,500 | $44.02 | $770,000 |
| Halpin Michael | Mar 11, 2024 | Sell | 7,874 | $44.71 | $350,000 |
| Flynn Sean C. | Mar 8, 2024 | Sell | 8,115 | $45.33 | $370,000 |
| Flynn Sean C. | Mar 8, 2024 | Sell | 8,115 | $45.33 | $370,000 |
| SIEGAL JONATHAN | Mar 7, 2024 | Sell | 1,634 | $45 | $74,000 |
| ZERBE ROBERT L MD | Feb 20, 2024 | Sell | 722 | $50.01 | $36,000 |
| Colangelo Dominick | Feb 15, 2024 | Sell | 17,500 | $48.85 | $850,000 |
| ZERBE ROBERT L MD | Jan 29, 2024 | Sell | 2,300 | $44.22 | $100,000 |
| ZERBE ROBERT L MD | Jan 25, 2024 | Sell | 200 | $44.02 | $8,800 |
| ZERBE ROBERT L MD | Jan 22, 2024 | Sell | 3,000 | $42.05 | $130,000 |
| ZERBE ROBERT L MD | Jan 22, 2024 | Sell | 2,500 | $42.06 | $110,000 |
| Colangelo Dominick | Jan 18, 2024 | Sell | 16,726 | $38.58 | $650,000 |
| ZERBE ROBERT L MD | Jan 12, 2024 | Sell | 2,200 | $38.09 | $84,000 |
| Colangelo Dominick | Dec 14, 2023 | Sell | 12,000 | $37.12 | $450,000 |
| Wotton Paul K | Dec 14, 2023 | Sell | 5,000 | $37.31 | $190,000 |
| Flynn Sean C. | Dec 14, 2023 | Sell | 106 | $37.45 | $4,000 |
| Flynn Sean C. | Dec 13, 2023 | Sell | 1,432 | $34.2 | $49,000 |
| Colangelo Dominick | Dec 7, 2023 | Sell | 12,000 | $33.84 | $410,000 |
| Colangelo Dominick | Dec 6, 2023 | Sell | 12,397 | $34.43 | $430,000 |
| Halpin Michael | Nov 30, 2023 | Sell | 17,447 | $35.41 | $620,000 |
| Hopper Jonathan Mark | Nov 20, 2023 | Sell | 5,000 | $36.4 | $180,000 |
| ZERBE ROBERT L MD | Nov 15, 2023 | Sell | 200 | $38 | $7,600 |
| ZERBE ROBERT L MD | Nov 15, 2023 | Sell | 100 | $38.06 | $3,800 |
| SIEGAL JONATHAN | Nov 15, 2023 | Sell | 662 | $37.695 | $25,000 |
| ZERBE ROBERT L MD | Jul 14, 2023 | Sell | 1,000 | $38.84 | $39,000 |
| ZERBE ROBERT L MD | Jun 22, 2023 | Sell | 3,000 | $36 | $110,000 |
| SIEGAL JONATHAN | Feb 2, 2023 | Sell | 330 | $31 | $10,000 |
| Colangelo Dominick | Jan 10, 2023 | Sell | 39,938 | $27.132 | $1.1M |
| SIEGAL JONATHAN | Oct 14, 2022 | Sell | 331 | $25.47 | $8,400 |
What's the latest insider transaction for Vericel?
The most recent insider transaction for Vericel was conducted by Colangelo Dominick, who sold 17,500 shares on June 13, 2024 at a price of $43.10 per share.
Which insider has sold the most VCEL stock over the last two years?
Colangelo Dominick has sold the most VCEL stock in the last 2 years, with a total value of $7M.
What is the total value of insider transactions for Vericel (VCEL) in the last 2 years?
The total value of insider transactions for Vericel in the last 2 years is negative, amounting to -$11M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Vericel's market confidence?
Over the last 2 years, insider transactions for Vericel have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.